NEW DELHI: It seems like India is inching further towards a vaccine solution to the COVID-19 disease, as the Prime Minister of the country is now asking States to chart out a plan for vaccine delivery. Yesterday, PM Narendra Modi reviewed COVID-19 vaccine development and manufacturing process at 3 facilities.
ALSO READ: BTR to elect new Chief Executive next month
According to reports, India's Prime Minister Narendra Modi yesterday undertook a three-city tour to conduct extensive review of the vaccine development and manufacturing process. The Prime Minister's tour took him to the Zydus Biotech Park in Ahmedabad, Bharat Biotech in Hyderabad and Serum Institute of India in Pune.
Pankaj Patel, Zydus chairman, disclosed to media that the Prime Minister's visit encouraged the team to put in more efforts.
The PM wound up the daylong tour with a visit to Pune-based Serum Institute of India, the manufacturing collaborator for Oxford University-AstraZeneca’s Covid vaccine that has shown over 70 per cent efficacy during recent trials.
“Visited the Zydus Biotech Park in Ahmedabad to know more about the indigenous DNA-based vaccine being developed by Zydus Cadila. I compliment the team for its effort,” the PM tweeted after his visit.
At Hyderabad, Mr. Modi took a briefing on Covaxin, India’s first indigenous Covid vaccine being developed by Bharat Biotech and the ICMR, which is currently in the Phase 3 of clinical trials.
At Serum Institute, the world’s largest vaccine manufacturer, the PM took stock of the late-stage Phase 3 trial process for Covishield.
To support our brand of fearless and investigative journalism, support us HERE.
The Inside Northeast app HERE for News, Views, and Reviews from Northeast India.
Do keep following us for news on-the-go. We deliver the Northeast.
Copyright©2022 Living Media India Limited. For reprint rights: Syndications Today